Search company, investor...

Excelsior

exradio.com

Stage

Acq - Fin | Acquired

About Excelsior

Provider of radio advertising sales and programming. The company produces and syndicates more than 25 music programs and prep services in a variety of formats to more than 2,500 radio stations nationwide. It also provides sales representation services for over 50 radio production companies across the US, producing over 100 different programs and services. The company also supplies software tools and web content for radio stations.

Headquarters Location

220 West 42nd Street

New York, New York, 10036,

United States

(212)419-2929

Missing: Excelsior's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Excelsior's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Excelsior Patents

Excelsior has filed 1 patent.

The 3 most popular patent topics include:

  • Neurological disorders
  • Psychiatric diagnosis
  • Rare diseases
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/28/2018

6/14/2022

Monoclinic minerals, Iron minerals, Oxide minerals, Concrete, Orthorhombic minerals

Grant

Application Date

3/28/2018

Grant Date

6/14/2022

Title

Related Topics

Monoclinic minerals, Iron minerals, Oxide minerals, Concrete, Orthorhombic minerals

Status

Grant

Latest Excelsior News

FDA Expands 510(k) Clearance for MERIT’s Cloud-Based Imaging Management Platform, EXCELSIOR

Nov 15, 2022

News Provided By Share This Article EXCELSIOR, MERIT's cloud-based software platform EXCELSIOR Unstructured Image Data Sources This expansion of our 510(k) clearance shows our commitment to developing new capabilities for EXCELSIOR while maintaining the highest regulatory standards.” — Nathan Diers, VP of Product Development at MERIT MADISON, WI, UNITED STATES , November 15, 2022 / EINPresswire.com / -- MERIT CRO, Inc., a global endpoint service provider specializing in multiple therapeutic areas, announced today that its EXCELSIOR(TM) imaging software has received expansion of its FDA 510(k) market clearance (K#220929). The expanded clearance includes new indications for use such as interpretation and evaluation of radiologic images (CT, MR and PET) in clinical trials. In 2013, EXCELSIOR received FDA 510(k) clearance as a class 2 medical device for managing ophthalmic clinical trial data. “We are excited to bring EXCELSIOR’s latest imaging technologies for data standardization, analysis, and reading to new indications,” said Yijun Huang, Co-Founder and CEO of MERIT. “This new expansion furthers our efforts to be ‘your clinical trial endpoint expert.’” Nathan Diers, VP of Product Development at MERIT, said “EXCELSIOR is a cloud-based software platform that offers end-to-end workflow management for managing the clinical data and images in clinical trials. This expansion of our 510(k) clearance shows our commitment to developing new capabilities for EXCELSIOR while maintaining the highest regulatory standards.” ABOUT MERIT MERIT ( https://meritcro.com/ ) is an innovative, global clinical trial endpoint services provider working in a variety of therapeutic areas, including ophthalmology, respiratory, oncology, cardiac safety, dermatology, and neurology. We partner with CROs as well as pharmaceutical and biotech companies to deliver reliable endpoint services in multi-regional clinical trials. Together our work advances and accelerates the improvement of therapeutic options for patients worldwide. MERIT’s EXCELSIOR technology platform increases accuracy and efficiency by providing a suite of advanced endpoint analysis tools designed based on our extensive collaboration with biopharma companies. Stacy Sanderson

Excelsior Frequently Asked Questions (FAQ)

  • Where is Excelsior's headquarters?

    Excelsior's headquarters is located at 220 West 42nd Street, New York.

  • What is Excelsior's latest funding round?

    Excelsior's latest funding round is Acq - Fin.

  • Who are the investors of Excelsior?

    Investors of Excelsior include Oaktree Capital Management and Lincolnshire Management.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.